Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
Clinical Priority Program (CPP) Clinical Outcome Measurement of Fracture Treatment:
1 other identifier
observational
1,500
6 countries
15
Brief Summary
Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2019
CompletedFirst Posted
Study publicly available on registry
October 2, 2019
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 6, 2026
March 1, 2026
5.9 years
September 20, 2019
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis
* Radiographic measurements o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\]) * Patient related outcomes * Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference * Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms) * Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms) * Loading/Activity pattern analysis: * Number of steps with weight-bearing \>80% body-weight (weight in kg) * pressure distribution \[N/cm2\] * center of pressure \[mm\] * ground reaction forces \[N\] * temporal and spatial parameters (time spent during gait \[min\], stance time \[s\], swing time \[s\], double support time \[s\], cadence \[r/min\], cycle time \[s\])
from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM
PROs that measure physical limitations: * PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities) * PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function) * Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability) * HOOS-12 * KOOS-12 * Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale) * PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)
from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
Secondary Outcomes (11)
PROMIS Pain Interference
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
PROMIS Depression
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
PROMIS Anxiety
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
PROMIS Ability to Participate in Social Roles and Activities
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
Pain Self-Efficacy Questionnaire (PSEQ)-2
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
- +6 more secondary outcomes
Interventions
All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.
Eligibility Criteria
All patients over 18 who have have suffered an isolated fracture of one of the following five bones: 1. proximal femur (hip); 2. tibial shaft (shin bone); 3. ankle; 4. proximal humerus (shoulder); and 5: distal radius ( wrist)
You may qualify if:
- Age 18 years and older
- Diagnosis of one of, isolated injury
- Hip fracture
- Tibial shaft fracture (with and without associated fibular fracture)
- Ankle/pilon fracture
- Proximal humerus fracture
- Distal radius fracture
- English, German, or Spanish speaking
- Informed consent obtained, i.e.:
- Ability to understand the content of the patient information/ICF
- Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
- Signed and dated EC/IRB approved written informed consent
You may not qualify if:
- More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
- Patients with multiple fractures
- Pathological fractures due to cancer
- Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
- Pregnancy or women planning to conceive within the study period
- Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
- Prisoners
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
- Patients unable to likely achieve anticipated Follow-up (FU)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Cedars-Sinai Department of Orthopaedics
Los Angeles, California, 90048, United States
University of Miami, Jackson Memorial Hospital Ryder Trauma Center
Miami, Florida, 33136, United States
Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
Boston, Massachusetts, 02114, United States
The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin
Austin, Texas, 78712, United States
Univ.-Klinik für Orthopädie und Traumatologie
Innsbruck, 6020, Austria
Fundación Santa Fe de Bogotá
Bogotá, 110121, Colombia
Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin
Berlin, 13353, Germany
University Hospital Freiburg
Freiburg im Breisgau, 79106, Germany
Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery
Homburg, 66421, Germany
Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau
Murnau am Staffelsee, 82418, Germany
Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen
Tübingen, 72076, Germany
University Medical Center Groningen
Groningen, 9700, Netherlands
Isala Clinics
Zwolle, 8000, Netherlands
Barts Health NHS Trust
London, E14DG, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, OX39DU, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marilyn Heng
Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
- PRINCIPAL INVESTIGATOR
Prakash Jayakumar
Dell Medical School, University of Texas at Austin
- PRINCIPAL INVESTIGATOR
Tim Pohlemann
Saarland University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2019
First Posted
October 2, 2019
Study Start
February 1, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share